Global Insulin Antidiabetics Market to reach USD 75 billion by 2023

1
Antidiabetics Market share to reach USD 116.1
billion by 2023 Fractovia.org
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights of Antidiabetics Market

• Geriatric demographic and obesity patients are
  likely to exhibit higher diabetes rates and will
  be the main drivers of this industry accounting
  for 360 million diabetes cases by 2023.
• Diabetes as a global health concern is being
  addressed by the government through various
  campaigns to inform and educate people about the
  effects and consequences of this disease and
  thus, motivate them to take effective measures
  for its control.
• For instance, NIDDK (National Institute of
  Diabetes and Digestive and Kidney Diseases) has
  organized educational campaigns like Control
  your diabetes for life,Small Steps, etc. to
  spread awareness about the importance of diabetes
  control.
• Multinational pharmaceutical companies like
  Pfizer, Merck, GlaxoSmithKline, Novartis, Eli
  Lilly, Sanofi, AstraZeneca are aiming towards
  expanding their market across 57.2 million people
  by 2025.
• Expanding their respective product portfolios
  will be the major growth strategy adopted by
  these players over the coming years. Generic drug
  manufacturers will also witness high growth
  opportunities in this market taking advantage of
  the reliance factor on low cost medicines.

3
Continued

• The Asia Pacific antidiabetics market is forecast
  to reach USD 28 billion by 2023. India and China
  are anticipated to be the revenue pockets due to
  high patient pool across these regions.
• In addition to this, the regional growth will be
  fueled by increasing penetration rates of insulin
  analogs. The European market is estimated to
  register a CAGR of 9 from 2016-2023. The growth
  is mainly attributed to the large obese
  population in this region.
• North America insulin antidiabetic market share
  worth USD 22.2 billion in 2015, will witness a
  noticeable surge in the coming years, driven by
  factors like better healthcare facilities in
  terms of accessibility, high disposable income,
  and favorable reimbursement policies.
• Antidiabetics market is becoming highly
  competitive with a variety of industry
  participants entering into the business space.
  Generic drug manufacturers have high scope
  wherein they can drive the revenue by
  manufacturing biosimilar medicines.

4
Europe Insulin Antidiabetics Market size, 2015
2023, (USD Million)

5

Browse Full Market Research Report Antidiabetics
Market _at_ http//bit.ly/2kPjtlE Request for a
Sample of this Research report _at_
https//www.fractovia.org/request-sample/185
6
Stay In Touch Website https//www.fractovia.org
Social Media